How Trump’s tariffs have created ‘upside potential’ for CSL shares

CSL Ltd (ASX: CSL) shares have gone backwards over the past year.

Shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock closed up 0.99% on Monday trading for $244.29.

Despite that welcome boost, shares remain down 10.61% in 12 months, underperforming the 5.56%…